Coya Therapeutics (COYA) Restructuring Costs (2024 - 2026)

Coya Therapeutics has disclosed Restructuring Costs across 3 years of filings, most recently posting $1.2 million for Q2 2026.

• In Q2 2026, Restructuring Costs fell 23.59% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $5.1 million (up 3.83% YoY), while the FY2025 annual figure was $5.5 million, up 20.27% from the prior year.
• Restructuring Costs came in at $1.2 million for Q2 2026 at Coya Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q2 2025 to a low of $991941.0 in Q4 2024.
• Average Restructuring Costs over 3 years is $1.3 million, with a median of $1.2 million recorded in 2025.
• Year-over-year, Restructuring Costs jumped 49.66% in 2025 and decreased 23.59% in 2026.
• Over 3 years, Restructuring Costs stood at $991941.0 in 2024, then surged by 49.66% to $1.5 million in 2025, then retreated by 20.45% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $1.2 million in Q2 2026, $1.3 million in Q1 2026, and $1.5 million in Q4 2025.